Abstract: Disclosed is a compact venturi scrubber, used for removing undesirable materials from a gas stream, that includes a gas inlet section, a discharge section aligned with the gas inlet section, the discharge section having a base defined by the intersection of the gas inlet section and the discharge section, a diverging interior surface, and a diverging angle defined by the diverging interior surface, a nozzle, and a liquid inlet through which a liquid scrubbing medium is introduced to the nozzle, wherein the nozzle produces a full spray pattern directed towards the base of the discharge section with a sufficiently large discharge angle so that a cross-sectional area of the full spray pattern produced by the nozzle at the point it intersects with the base of the discharge section fully covers, and substantially matches the size and shape of, the cross-sectional area of the base of the discharge section.

Abstract: Embodiments herein relate generally to distribution of flow into vessels containing packed beds of media. An example application of such beds is to pressure swing or temperature swing adsorption systems. Systems herein may include a vessel and a distributor for distributing flow into a lower portion of the vessel. The system may include: a vessel comprising a top head and a bottom head; and a bottom head feed/effluent nozzle. A lower distributor having at least one flow permitting surface is disposed within the vessel and encompasses an inlet of the bottom head feed/effluent nozzle. A flow gap is formed between a bottom portion of the lower distributor and the bottom head feed/effluent nozzle.

Abstract: Cycloalkyl amine compounds of Formula (I), wherein ring A is C3-C6 cycloalkyl, optionally substituted with one or more C1-C3 alkyl, and R5 is ORS2, in which RS2 is H or C1-C6 alkyl, or R5 and R6, together with the carbon atom to which they are attached, form C?O, for use in treating CNS disorders, including movement disorders, depressive disorders, sleep disorders, cognitive dysfunctions, obesity, sexual dysfunction and substance abuse.

Abstract: Embodiments herein relate generally to distribution of flow into vessels containing packed beds of media. An example application of such beds is to pressure swing or temperature swing adsorption systems. Systems herein may include a vessel and a distributor for distributing flow into a lower portion of the vessel. The system may include: a vessel comprising a top head and a bottom head; and a bottom head feed/effluent nozzle. A lower distributor having at least one flow permitting surface is disposed within the vessel and encompasses an inlet of the bottom head feed/effluent nozzle. A flow gap is formed between a bottom portion of the lower distributor and the bottom head feed/effluent nozzle.

Abstract: A pressure swing adsorption (PSA) system using two or more valves for controlling the flow of gases entering or exiting a bed of adsorbents is disclosed, where the two or more valves are opened sequentially (i.e., in at least two actions separated by a delay in time). The sequential opening of the valves may increase the degree to which adsorbed species are purged from the bed, and also facilitates more rapid execution of certain time steps of the PSA cycle, thus increasing adsorbent productivity The sequential opening of the valves may also allow for verification of valve operation by measuring either the absolute value, the slope (derivative) or the rate of change of derivative of the pressure, either in the adsorbent bed, in the downstream manifold, or in a volume of gas held in a buffer vessel.

Abstract: A pressure swing adsorption (PSA) system using two or more valves for controlling the flow of gases entering or exiting a bed of adsorbents is disclosed, where the two or more valves are opened sequentially (i.e., in at least two actions separated by a delay in time). The sequential opening of the valves may increase the degree to which adsorbed species are purged from the bed, and also facilitates more rapid execution of certain time steps of the PSA cycle, thus increasing adsorbent productivity The sequential opening of the valves may also allow for verification of valve operation by measuring either the absolute value, the slope (derivative) or the rate of change of derivative of the pressure, either in the adsorbent bed, in the downstream manifold, or in a volume of gas held in a buffer vessel.

Abstract: A recycling apparatus for spent protective atmosphere gas contaminated with fouling organic decomposition byproduct materials. The recycling apparatus includes a compressor having an inlet connected to a spent protective atmosphere gas supply line, and a solvent supply configured to supply solvent to a gas passage at or upstream of the compressor. The recycling apparatus also includes a first chamber connected to an outlet of the compressor, where the first chamber is configured to receive compressed gas from the compressor and to collect a mixture including the solvent and any contaminants entrapped or dissolved in the solvent.

Abstract: A recycling apparatus for spent protective atmosphere gas contaminated with fouling organic decomposition byproduct materials. The recycling apparatus includes a compressor having an inlet connected to a spent protective atmosphere gas supply line, and a solvent supply configured to supply solvent to a gas passage at or upstream of the compressor. The recycling apparatus also includes a first chamber connected to an outlet of the compressor, where the first chamber is configured to receive compressed gas from the compressor and to collect a mixture including the solvent and any contaminants entrapped or dissolved in the solvent.

Abstract: A recycling apparatus for spent protective atmosphere gas contaminated with fouling organic decomposition byproduct materials. The recycling apparatus includes a compressor having an inlet connected to a spent protective atmosphere gas supply line, and a solvent supply configured to supply solvent to a gas passage at or upstream of the compressor. The recycling apparatus also includes a first chamber connected to an outlet of the compressor, where the first chamber is configured to receive compressed gas from the compressor and to collect a mixture including the solvent and any contaminants entrapped or dissolved in the solvent.

Abstract: A system for recycling vented atmosphere gas discharged from a heat treatment chamber utilizing a protective atmosphere gas therein. The system includes an atmosphere recycling apparatus configured to receive the vented atmosphere gas. The atmosphere recycling apparatus includes a gas separator configured to separate the vented atmosphere gas into a purified atmosphere gas stream and an impure stream. The atmosphere recycling apparatus is configured to feed the purified atmosphere gas stream to the heat treatment chamber. A storage vessel can be provided to receive the purified atmosphere gas stream from the atmosphere recycling apparatus, and configured to supplement an atmosphere gas supply to the heat treatment chamber with the purified atmosphere gas stream.

Abstract: A pressure swing adsorption system including a plurality of vessels having one or more layers of adsorbent material therein, a feed gas channel, a waste channel, and a product channel. The system also includes at least one parallel channel connected to each of the vessels via a respective conduit with a valve. At least one pressure measuring device i configured to measure a pressure within the parallel channel. And, a controller is provided that is configured to monitor the at least one pressure measured by the at least one pressure measuring device during a PSA cycle performed within the PSA system, in order to determine the performance of the cycle and monitor proper operation of the system.

Abstract: A recycling apparatus for spent protective atmosphere gas contaminated with fouling organic decomposition byproduct materials. The recycling apparatus includes a compressor having an inlet connected to a spent protective atmosphere gas supply line, and a solvent supply configured to supply solvent to a gas passage at or upstream of the compressor. The recycling apparatus also includes a first chamber connected to an outlet of the compressor, where the first chamber is configured to receive compressed gas from the compressor and to collect a mixture including the solvent and any contaminants entrapped or dissolved in the solvent.

Abstract: compounds of formula I ##STR1## wherein R.sup.1 represents a C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, C.sub.3-8 cycloalkyl(C.sub.1-8)alkyl, C.sub.1-8 hydroxyalkyl, C.sub.1-8 alkylthio, phenyl or substituted phenyl;R.sup.3 represents a C.sub.1-8 alkyl, C.sub.2-8 alkenyl, C.sub.2-8 alkynyl, CO2(C.sub.1-8)alkyl, CO.sub.2 (C.sub.2-8) alkenyl, C.sub.1-8 alkylthio, (C.sub.1-2)alkyl CO.sub.2 (C.sub.1-8) alkyl or C.sub.1-8 aldehydroalkyl where the aldehyde function is protected by a suitable protecting group (for example, an acetal such as a dimethyl acetal);R.sup.4 represents a hydrogen atom, C.sub.1-8 alkyl or C.sub.2-8 alkenyl;Z represents a group (CH.sub.2).sub.n or a branched alkyl chain;n is 1 to 8;and each of a, b and c is independently a single or a double bond;can be prepared relatively easily and in good xxx at room temperature by reacting a compound of general formula II ##STR2## wherein R.sup.2, R.sup.3, R.sup.

Abstract: Compounds of either of general formulae I and II: ##STR1## wherein: R.sup.1, R.sup.2, R.sup.3, R.sup.5, R.sup.6, a, b, c, and d are variables.These compounds are useful in the treatment of hypercholesterolaemia in general and arteriosclerosis, familial hypercholesterolaemia or hyperlipidaemia in particular.

Abstract: Pyridine derivatives of formula ##STR1## their heteroaromatic N-oxides and their pharmaceutically acceptable acid addition salts are disclosed. In the formula z is 0, 1 and 2; R is hydrogen, hydroxy, lower alkyl, lower alkoxy, halogen, trifluoromethyl, nitro, amino, (lower)alkylamino or di(lower)alkylamino; R.sup.1 is hydrogen or lower alkyl; R.sup.2 is --(CH.sub.2).sub.n --R.sup.3 or --CH.sub.2 --CH.dbd.CH--(CH.sub.2).sub.m --R.sup.3 or --CH.sub.2.C.tbd.C.(CH.sub.2).sub.m --R.sup.3 where n is 1 to 6, and m is 0 to 3; and R.sup.3 is a ring of formula ##STR2## The compounds exhibit activity as 5-HT.sub.1A agonists, antagonists or partial agonists and are used for the treatment of CNS disorders, e.g. anxiety, as antihypertensives and in treating anorexia.

Abstract: Pyridine derivatives of formula ##STR1## their heteroaromatic N-oxides and their pharmaceutically acceptable acid addition salts are disclosed. In the formula z is 0, 1 and 2 and R, R.sup.1, R.sup.2 and R.sup.2 have specified meanings. The compounds exhibit activity as 5-HT.sub.1A agonists, antagonists or partial agonists and are useful for the treatment of CNS disorders e.g. anxiety, as antihypertensives and in treating anorexia.

Abstract: Novel quinazoline and cinnoline derivatives having the formula ##STR1## (wherein one of A and B is CH and the other one of A and B is N; X.sub.1 is halogen or CF.sub.3 and X.sub.3 is one of the groups II, III, IV or V ##STR2## where Q is lower alkylene; R.sub.1 is hydrogen or lower alkyl; R.sub.2 and R.sub.3 are independently lower alkyl or R.sub.2 and R.sub.3 are a divalent radical such that HNR.sub.2 R.sub.3 is a secondary cyclic amine with 5 to 7 ring atoms; R.sub.4 is lower alkyl; n is 0 or 1; the rings shown in formulae III and IV are piperidine or pyrrolidine optionally substituted by lower alkyl; and the ring shown in formula V is piperazine optionally substituted by lower alkyl) and their pharmaceutically acceptable salts are useful as pharmaceuticals particularly as anti-hypertensives. Novel intermediates are also described including the corresponding sulphonic acids of formula I ( (where A, B and X.sub.1 are defined above and X.sub.3 is OH).

Abstract: Pyrimidoindoles of formula (I) ##STR1## and their pharmaceutically acceptable acid addition salts, wherein R represents lower alkyl a mono- or bicyclic aryl radical or a group of mormula R.sup.3 O--B--[where R.sup.3 O is (lower)alkoxy,aryl(lower)alkoxy or hydroxy and B is a lower alkylene chain optionally containing one double or triple bond], R.sup.1 and R.sup.2 which may be the same or different each represent hydrogen, hydroxyl, lower alkyl, lower alkoxy, halo(lower)alkyl, halogen, amino or mono- or di(lower) alkylamino and A, together with the carbon atom to which it is attached, represents 5, 6 or 7 membered saturated carbocyclic or heterocyclic ring, are useful as hypoglyceamics.

Abstract: New compounds having the formula I ##STR1## where one of A and B is CH or N, the other of A and B is CH, Q is lower alkylene, R is lower alkyl, X.sub.1 is halogen or trifluoromethyl and X.sub.2 and X.sub.3 are independently selected from hydrogen, halogen, trifluoromethyl, lower alkoxy and lower alkyl and the pharmaceutically acceptable acid additions are disclosed as anti-hypertensive agents. New compounds having the formula II ##STR2## where Q, R, X.sub.2 and X.sub.3 are as explained above and n is 0 or 1 and their acid addition salts are useful as intermediates.

Abstract: Compounds of formula ##STR1## wherein A represents a lower alkylene chain optionally containing one double or triple bond, RO represents (lower)alkoxy, aryl(lower)alkoxy, hydroxy or protected hydroxy, R.sup.1 and R.sup.2 which may be the same or different each represent hydrogen, hydroxyl, lower alkyl, lower alkoxy, halo(lower)alkyl, halogen, amino or mono- or di(lower)alkylamino and R.sup.3 and R.sup.4 each independently represent hydrogen or lower alkyl and their pharmaceutically acceptable acid addition salts are useful as hypoglycaemics or as intermediates for hypoglycaemics.